A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Peginterferon alfa-2a | The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Peginterferon alfa-2a. |
| Pegfilgrastim | The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Pegfilgrastim. |
| Peginterferon alfa-2b | The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Peginterferon alfa-2b. |
| Pegaspargase | The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Pegaspargase. |
| Pegademase | The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Pegademase. |
| Pegvisomant | The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Pegvisomant. |
| Heptaethylene glycol | The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Propylene glycol. |
| Pegaptanib | The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Propylene glycol. |
| Egaptivon pegol | The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Propylene glycol. |
| PEG-uricase | The therapeutic efficacy of PEG-uricase can be decreased when used in combination with Propylene glycol. |
| Peginterferon alfacon-1 | The therapeutic efficacy of Peginterferon alfacon-1 can be decreased when used in combination with Propylene glycol. |
| GlycoPEG-GCSF | The therapeutic efficacy of GlycoPEG-GCSF can be decreased when used in combination with Propylene glycol. |
| Pegnivacogin | The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Propylene glycol. |
| Pegpleranib | The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Propylene glycol. |
| Pegsunercept | The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Propylene glycol. |
| Polidocanol | The therapeutic efficacy of Polidocanol can be decreased when used in combination with Propylene glycol. |
| Peginesatide | The therapeutic efficacy of Peginesatide can be decreased when used in combination with Propylene glycol. |
| Certolizumab pegol | The therapeutic efficacy of Certolizumab pegol can be decreased when used in combination with Propylene glycol. |
| Methoxy polyethylene glycol-epoetin beta | The therapeutic efficacy of Methoxy polyethylene glycol-epoetin beta can be decreased when used in combination with Propylene glycol. |
| Peginterferon beta-1a | The therapeutic efficacy of Peginterferon beta-1a can be decreased when used in combination with Propylene glycol. |
| Pegloticase | The therapeutic efficacy of Pegloticase can be decreased when used in combination with Propylene glycol. |
| Antihemophilic factor (recombinant), PEGylated | The therapeutic efficacy of Antihemophilic factor (recombinant), PEGylated can be decreased when used in combination with Propylene glycol. |
| Insulin peglispro | The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Propylene glycol. |
| Eptacog alfa pegol (activated) | The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Propylene glycol. |
| Olaptesed Pegol | The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Propylene glycol. |
| Abicipar Pegol | The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Propylene glycol. |
| Lexaptepid pegol | The therapeutic efficacy of Lexaptepid pegol can be decreased when used in combination with Propylene glycol. |
| Cepeginterferon alfa-2B | The therapeutic efficacy of Cepeginterferon alfa-2B can be decreased when used in combination with Propylene glycol. |
| Pegvaliase | The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Propylene glycol. |
| Pegamotecan | The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Propylene glycol. |
| Lipegfilgrastim | The therapeutic efficacy of Lipegfilgrastim can be decreased when used in combination with Propylene glycol. |
| Nonacog beta pegol | The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Propylene glycol. |
| Damoctocog alfa pegol | The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Propylene glycol. |
| Elapegademase | The therapeutic efficacy of Elapegademase can be decreased when used in combination with Propylene glycol. |
| Rurioctocog alfa pegol | The therapeutic efficacy of Rurioctocog alfa pegol can be decreased when used in combination with Propylene glycol. |